Evaluating the performance of a clinicopathological prognostic nomogram and utility of the 40-gene expression profile (40-GEP) test in refining risk of metastasis in high-risk cutaneous squamous cell carcinoma (HR-cSCC) patients

Saved in:
Bibliographic Details
Main Authors: A. Jambusaria-Pahlajani, J. Cañueto, C. Cardona-Machado, A. Prasai, C. Bailey, J. Siegel, A. Fitzgerald, E. Vetto, E. Ruiz
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:EJC Skin Cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2772611824000478
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846159115431182336
author A. Jambusaria-Pahlajani
J. Cañueto
C. Cardona-Machado
A. Prasai
C. Bailey
J. Siegel
A. Fitzgerald
E. Vetto
E. Ruiz
author_facet A. Jambusaria-Pahlajani
J. Cañueto
C. Cardona-Machado
A. Prasai
C. Bailey
J. Siegel
A. Fitzgerald
E. Vetto
E. Ruiz
author_sort A. Jambusaria-Pahlajani
collection DOAJ
format Article
id doaj-art-8c9c15cadd684ecd9f4ed5043550941a
institution Kabale University
issn 2772-6118
language English
publishDate 2024-01-01
publisher Elsevier
record_format Article
series EJC Skin Cancer
spelling doaj-art-8c9c15cadd684ecd9f4ed5043550941a2024-11-24T04:14:39ZengElsevierEJC Skin Cancer2772-61182024-01-012100059Evaluating the performance of a clinicopathological prognostic nomogram and utility of the 40-gene expression profile (40-GEP) test in refining risk of metastasis in high-risk cutaneous squamous cell carcinoma (HR-cSCC) patientsA. Jambusaria-Pahlajani0J. Cañueto1C. Cardona-Machado2A. Prasai3C. Bailey4J. Siegel5A. Fitzgerald6E. Vetto7E. Ruiz8Dell Medical School at the University of Texas, Division of Dermatology, Austin, Texas, United States of AmericaComplejo Asistencial Universitario de Salamanca, Department of Dermatology, Salamanca, Spain; Instituto de Biología Celular y Molecular de Cáncer (CIC-IBMCC)-CSIC/USAL, Salamanca, SpainInstituto de Biología Celular y Molecular de Cáncer (CIC-IBMCC)-CSIC/USAL, Salamanca, Spain; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, SpainCastle Biosciences Inc, R & D, Friendswood, Texas, United States of AmericaCastle Biosciences Inc, Bioinformatics, Friendswood, Texas, United States of AmericaCastle Biosciences Inc, Bioinformatics, Friendswood, Texas, United States of AmericaCastle Biosciences Inc, R & D, Friendswood, Texas, United States of AmericaCastle Biosciences Inc, R & D, Friendswood, Texas, United States of AmericaBrigham and Women's Hospital, Harvard Medical School, Department of Dermatology, Boston, Massachusetts, United States of Americahttp://www.sciencedirect.com/science/article/pii/S2772611824000478
spellingShingle A. Jambusaria-Pahlajani
J. Cañueto
C. Cardona-Machado
A. Prasai
C. Bailey
J. Siegel
A. Fitzgerald
E. Vetto
E. Ruiz
Evaluating the performance of a clinicopathological prognostic nomogram and utility of the 40-gene expression profile (40-GEP) test in refining risk of metastasis in high-risk cutaneous squamous cell carcinoma (HR-cSCC) patients
EJC Skin Cancer
title Evaluating the performance of a clinicopathological prognostic nomogram and utility of the 40-gene expression profile (40-GEP) test in refining risk of metastasis in high-risk cutaneous squamous cell carcinoma (HR-cSCC) patients
title_full Evaluating the performance of a clinicopathological prognostic nomogram and utility of the 40-gene expression profile (40-GEP) test in refining risk of metastasis in high-risk cutaneous squamous cell carcinoma (HR-cSCC) patients
title_fullStr Evaluating the performance of a clinicopathological prognostic nomogram and utility of the 40-gene expression profile (40-GEP) test in refining risk of metastasis in high-risk cutaneous squamous cell carcinoma (HR-cSCC) patients
title_full_unstemmed Evaluating the performance of a clinicopathological prognostic nomogram and utility of the 40-gene expression profile (40-GEP) test in refining risk of metastasis in high-risk cutaneous squamous cell carcinoma (HR-cSCC) patients
title_short Evaluating the performance of a clinicopathological prognostic nomogram and utility of the 40-gene expression profile (40-GEP) test in refining risk of metastasis in high-risk cutaneous squamous cell carcinoma (HR-cSCC) patients
title_sort evaluating the performance of a clinicopathological prognostic nomogram and utility of the 40 gene expression profile 40 gep test in refining risk of metastasis in high risk cutaneous squamous cell carcinoma hr cscc patients
url http://www.sciencedirect.com/science/article/pii/S2772611824000478
work_keys_str_mv AT ajambusariapahlajani evaluatingtheperformanceofaclinicopathologicalprognosticnomogramandutilityofthe40geneexpressionprofile40geptestinrefiningriskofmetastasisinhighriskcutaneoussquamouscellcarcinomahrcsccpatients
AT jcanueto evaluatingtheperformanceofaclinicopathologicalprognosticnomogramandutilityofthe40geneexpressionprofile40geptestinrefiningriskofmetastasisinhighriskcutaneoussquamouscellcarcinomahrcsccpatients
AT ccardonamachado evaluatingtheperformanceofaclinicopathologicalprognosticnomogramandutilityofthe40geneexpressionprofile40geptestinrefiningriskofmetastasisinhighriskcutaneoussquamouscellcarcinomahrcsccpatients
AT aprasai evaluatingtheperformanceofaclinicopathologicalprognosticnomogramandutilityofthe40geneexpressionprofile40geptestinrefiningriskofmetastasisinhighriskcutaneoussquamouscellcarcinomahrcsccpatients
AT cbailey evaluatingtheperformanceofaclinicopathologicalprognosticnomogramandutilityofthe40geneexpressionprofile40geptestinrefiningriskofmetastasisinhighriskcutaneoussquamouscellcarcinomahrcsccpatients
AT jsiegel evaluatingtheperformanceofaclinicopathologicalprognosticnomogramandutilityofthe40geneexpressionprofile40geptestinrefiningriskofmetastasisinhighriskcutaneoussquamouscellcarcinomahrcsccpatients
AT afitzgerald evaluatingtheperformanceofaclinicopathologicalprognosticnomogramandutilityofthe40geneexpressionprofile40geptestinrefiningriskofmetastasisinhighriskcutaneoussquamouscellcarcinomahrcsccpatients
AT evetto evaluatingtheperformanceofaclinicopathologicalprognosticnomogramandutilityofthe40geneexpressionprofile40geptestinrefiningriskofmetastasisinhighriskcutaneoussquamouscellcarcinomahrcsccpatients
AT eruiz evaluatingtheperformanceofaclinicopathologicalprognosticnomogramandutilityofthe40geneexpressionprofile40geptestinrefiningriskofmetastasisinhighriskcutaneoussquamouscellcarcinomahrcsccpatients